Exploration of the Beneficial Role of Circulating Adiponectin Levels on Cardiovascular Disease Risk Reveals T-cadherin as a Putative Target for Therapeutic Intervention (S30.001)
To explore whether circulating adiponectin may be causally associated with lower cardiovascular disease (CVD) risk, and provide mechanistic insights of this association, leveraging large-scale genomics data.
Authors
- Christopher M. Anderson (ORCID: https://orcid.org/0000-0003-0678-3002)
- Jonathan Rosand (ORCID: https://orcid.org/0000-0002-1014-9138)
- Chirantan Banerjee
- Magdy Selim (ORCID: https://orcid.org/0000-0002-1936-3173)
- Dipender Gill (ORCID: https://orcid.org/0000-0001-7312-7078)
- Marios K. Georgakis (ORCID: https://orcid.org/0000-0003-3507-3659)
- Vasileios‐Arsenios Lioutas (ORCID: https://orcid.org/0000-0002-8521-0036)
- Evangelos Pavlos Myserlis (ORCID: https://orcid.org/0000-0002-7310-624X)
Institutions
- Brigham and Women's Hospital (US)
- Medical University of South Carolina (US)
- Hadassah Medical Center (IL)
- Massachusetts General Hospital (US)
- Imperial College London (GB)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211606
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00